http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 04 Jun 2026 13:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Emerging+Muscle-Preservation+Category+Expanding+the+GLP-1+Opportunity/26604632.html <p align="center">• Analysis of 20 muscle-preservation programs highlights a rapidly emerging category designed to enhance long-term obesity treatment outcomes</p> <p align="center">• PatentVest’s report reveals how combination therapy IP, body-composition optimization, and strategic acquisitions may shape the next phase of obesity therapeutics</p> <p align="left">Dallas, Texas, June 04, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, “<a href="https://www.globenewswire.com/Tracker?data=BNRoQD1VTrhO0NQNdcTckFFnwP-2aqIXP1AHndllxJYLuMKZ7GgXnzjdwtdpskmwebWNOqpd0Yc0a9tzJHAqJo3v67CtIk_6FW-5ygRBQiXYpL95vYxgvDYj-OHkI9om1b-2St-qv8ZYMicZ6aGe6zfPg_7dQAfe9IlkoQMmV5_mvnciYajn4CQrvqMuIQxBxvUCoNpijvodI5m6lCtZf0gPgOiAkNGBYAT5Q9jMwxCrvjsDvjsvJUHo_D37tm6adEOpfSo1KSvhLZ3OdEr8Fw==" rel="nofollow" target="_blank"><b><i><u>The Muscle Problem: </u></i></b><b><i><u>How Myostatin Could Expand the GLP-1 Opportunity</u></i></b></a>” This comprehensive study provides a strategic analysis of the emerging muscle-preservation category developing alongside http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Emerging+Muscle-Preservation+Category+Expanding+the+GLP-1+Opportunity/26604632.html Thu, 04 Jun 2026 13:05:00 -0400 MDBH http://www.streetinsider.com/Globe+Newswire/New+PatentVest+Pulse+Report+Maps+the+Emerging+Muscle-Preservation+Category+Expanding+the+GLP-1+Opportunity/26604632.html <p align="center">• Analysis of 20 muscle-preservation programs highlights a rapidly emerging category designed to enhance long-term obesity treatment outcomes</p> <p align="center">• PatentVest’s report reveals how combination therapy IP, body-composition optimization, and strategic acquisitions may shape the next phase of obesity therapeutics</p> <p align="left">Dallas, Texas, June 04, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, “<a href="https://www.globenewswire.com/Tracker?data=BNRoQD1VTrhO0NQNdcTckFFnwP-2aqIXP1AHndllxJYLuMKZ7GgXnzjdwtdpskmwebWNOqpd0Yc0a9tzJHAqJo3v67CtIk_6FW-5ygRBQiXYpL95vYxgvDYj-OHkI9om1b-2St-qv8ZYMicZ6aGe6zfPg_7dQAfe9IlkoQMmV5_mvnciYajn4CQrvqMuIQxBxvUCoNpijvodI5m6lCtZf0gPgOiAkNGBYAT5Q9jMwxCrvjsDvjsvJUHo_D37tm6adEOpfSo1KSvhLZ3OdEr8Fw==" rel="nofollow" target="_blank"><b><i><u>The Muscle Problem: </u></i></b><b><i><u>How Myostatin Could Expand the GLP-1 Opportunity</u></i></b></a>” This comprehensive study provides a strategic analysis of the emerging muscle-preservation category developing alongside http://www.streetinsider.com/Globe+Newswire/New+PatentVest+Pulse+Report+Maps+the+Emerging+Muscle-Preservation+Category+Expanding+the+GLP-1+Opportunity/26604632.html Thu, 04 Jun 2026 13:05:00 -0400 MDBH http://www.streetinsider.com/Press+Releases/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html <p>Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO &amp; Co-Founder, <strong>Chris Marlett</strong>, will present live at the Planet MicroCap Las Vegas 2026 conference on <strong>Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT</strong> at the Bellagio Resort &amp; Hotel in Las Vegas, Nevada.</p> <p>Marlett will provide an overview of MDB’s unique <b>public venture capital</b> model built to provide <b>rational capital for founders</b> of early-stage, category defining companies and <b>asymmetric upside with public market liquidity for investors. </b></p> <p><strong>Live Webcast:</strong> <a href="https://www.globenewswire.com/Tracker?data=1HWf0oRHcReRubF2Q5T3sElnHhUXdojCxhvJBf7BYuioB9YLDqC48blJBxRLZkQOyQhhT-Mjt8zhhZYQGZDX71Y3ttuS4tNDYA-zI5zq0_BdZiNpQipglZZgmbRfms0r13e8vFNcPNLpQ447q5RcNnFhz4m3Se16qkBn3EIwMmF9thBXPN5cC1SLUrtvGAnw" rel="nofollow" http://www.streetinsider.com/Press+Releases/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html Wed, 03 Jun 2026 16:05:00 -0400 MDBH MDBH MDBH http://www.streetinsider.com/Press+Releases/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html <p>Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO &amp; Co-Founder, <strong>Chris Marlett</strong>, will present live at the Planet MicroCap Las Vegas 2026 conference on <strong>Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT</strong> at the Bellagio Resort &amp; Hotel in Las Vegas, Nevada.</p> <p>Marlett will provide an overview of MDB’s unique <b>public venture capital</b> model built to provide <b>rational capital for founders</b> of early-stage, category defining companies and <b>asymmetric upside with public market liquidity for investors. </b></p> <p><strong>Live Webcast:</strong> <a href="https://www.globenewswire.com/Tracker?data=1HWf0oRHcReRubF2Q5T3sElnHhUXdojCxhvJBf7BYuioB9YLDqC48blJBxRLZkQOyQhhT-Mjt8zhhZYQGZDX71Y3ttuS4tNDYA-zI5zq0_BdZiNpQipglZZgmbRfms0r13e8vFNcPNLpQ447q5RcNnFhz4m3Se16qkBn3EIwMmF9thBXPN5cC1SLUrtvGAnw" rel="nofollow" http://www.streetinsider.com/Press+Releases/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html Wed, 03 Jun 2026 16:05:00 -0400 MDBH MDBH MDBH http://www.streetinsider.com/Press+Releases/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html <p>Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO &amp; Co-Founder, <strong>Chris Marlett</strong>, will present live at the Planet MicroCap Las Vegas 2026 conference on <strong>Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT</strong> at the Bellagio Resort &amp; Hotel in Las Vegas, Nevada.</p> <p>Marlett will provide an overview of MDB’s unique <b>public venture capital</b> model built to provide <b>rational capital for founders</b> of early-stage, category defining companies and <b>asymmetric upside with public market liquidity for investors. </b></p> <p><strong>Live Webcast:</strong> <a href="https://www.globenewswire.com/Tracker?data=1HWf0oRHcReRubF2Q5T3sElnHhUXdojCxhvJBf7BYuioB9YLDqC48blJBxRLZkQOyQhhT-Mjt8zhhZYQGZDX71Y3ttuS4tNDYA-zI5zq0_BdZiNpQipglZZgmbRfms0r13e8vFNcPNLpQ447q5RcNnFhz4m3Se16qkBn3EIwMmF9thBXPN5cC1SLUrtvGAnw" rel="nofollow" http://www.streetinsider.com/Press+Releases/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html Wed, 03 Jun 2026 16:05:00 -0400 MDBH MDBH MDBH http://www.streetinsider.com/Globe+Newswire/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html <p>Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO &amp; Co-Founder, <strong>Chris Marlett</strong>, will present live at the Planet MicroCap Las Vegas 2026 conference on <strong>Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT</strong> at the Bellagio Resort &amp; Hotel in Las Vegas, Nevada.</p> <p>Marlett will provide an overview of MDB’s unique <b>public venture capital</b> model built to provide <b>rational capital for founders</b> of early-stage, category defining companies and <b>asymmetric upside with public market liquidity for investors. </b></p> <p><strong>Live Webcast:</strong> <a href="https://www.globenewswire.com/Tracker?data=1HWf0oRHcReRubF2Q5T3sElnHhUXdojCxhvJBf7BYuioB9YLDqC48blJBxRLZkQOyQhhT-Mjt8zhhZYQGZDX71Y3ttuS4tNDYA-zI5zq0_BdZiNpQipglZZgmbRfms0r13e8vFNcPNLpQ447q5RcNnFhz4m3Se16qkBn3EIwMmF9thBXPN5cC1SLUrtvGAnw" rel="nofollow" http://www.streetinsider.com/Globe+Newswire/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html Wed, 03 Jun 2026 16:05:00 -0400 MDBH MDBH MDBH http://www.streetinsider.com/Globe+Newswire/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html <p>Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO &amp; Co-Founder, <strong>Chris Marlett</strong>, will present live at the Planet MicroCap Las Vegas 2026 conference on <strong>Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT</strong> at the Bellagio Resort &amp; Hotel in Las Vegas, Nevada.</p> <p>Marlett will provide an overview of MDB’s unique <b>public venture capital</b> model built to provide <b>rational capital for founders</b> of early-stage, category defining companies and <b>asymmetric upside with public market liquidity for investors. </b></p> <p><strong>Live Webcast:</strong> <a href="https://www.globenewswire.com/Tracker?data=1HWf0oRHcReRubF2Q5T3sElnHhUXdojCxhvJBf7BYuioB9YLDqC48blJBxRLZkQOyQhhT-Mjt8zhhZYQGZDX71Y3ttuS4tNDYA-zI5zq0_BdZiNpQipglZZgmbRfms0r13e8vFNcPNLpQ447q5RcNnFhz4m3Se16qkBn3EIwMmF9thBXPN5cC1SLUrtvGAnw" rel="nofollow" http://www.streetinsider.com/Globe+Newswire/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html Wed, 03 Jun 2026 16:05:00 -0400 MDBH MDBH MDBH http://www.streetinsider.com/Globe+Newswire/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html <p>Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO &amp; Co-Founder, <strong>Chris Marlett</strong>, will present live at the Planet MicroCap Las Vegas 2026 conference on <strong>Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT</strong> at the Bellagio Resort &amp; Hotel in Las Vegas, Nevada.</p> <p>Marlett will provide an overview of MDB’s unique <b>public venture capital</b> model built to provide <b>rational capital for founders</b> of early-stage, category defining companies and <b>asymmetric upside with public market liquidity for investors. </b></p> <p><strong>Live Webcast:</strong> <a href="https://www.globenewswire.com/Tracker?data=1HWf0oRHcReRubF2Q5T3sElnHhUXdojCxhvJBf7BYuioB9YLDqC48blJBxRLZkQOyQhhT-Mjt8zhhZYQGZDX71Y3ttuS4tNDYA-zI5zq0_BdZiNpQipglZZgmbRfms0r13e8vFNcPNLpQ447q5RcNnFhz4m3Se16qkBn3EIwMmF9thBXPN5cC1SLUrtvGAnw" rel="nofollow" http://www.streetinsider.com/Globe+Newswire/MDB+Capital+to+Present+at+Planet+MicroCap+Las+Vegas+2026+Along+with+Subsidiary+PatentVest+and+Portfolio+Company+Buda+Juice/26598710.html Wed, 03 Jun 2026 16:05:00 -0400 MDBH MDBH MDBH http://www.streetinsider.com/Press+Releases/PatentVest+Launches+New+Case+Studies+Section+Featuring+Strategic+AI+IP+Engagement+with+Docana/26518364.html <p align="center">· New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP positioning.</p> <p align="center">· The launch introduces a new Case Studies section on the PatentVest website focused on real-world examples of strategic IP leadership and innovation management.</p> <p align="left">Dallas, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the launch of a new Case Studies section on its website, beginning with a featured engagement with Docana, an artificial intelligence company operating within http://www.streetinsider.com/Press+Releases/PatentVest+Launches+New+Case+Studies+Section+Featuring+Strategic+AI+IP+Engagement+with+Docana/26518364.html Tue, 19 May 2026 09:00:00 -0400 MDBH O.59331052 http://www.streetinsider.com/Press+Releases/PatentVest+Launches+New+Case+Studies+Section+Featuring+Strategic+AI+IP+Engagement+with+Docana/26518364.html <p align="center">· New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP positioning.</p> <p align="center">· The launch introduces a new Case Studies section on the PatentVest website focused on real-world examples of strategic IP leadership and innovation management.</p> <p align="left">Dallas, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the launch of a new Case Studies section on its website, beginning with a featured engagement with Docana, an artificial intelligence company operating within http://www.streetinsider.com/Press+Releases/PatentVest+Launches+New+Case+Studies+Section+Featuring+Strategic+AI+IP+Engagement+with+Docana/26518364.html Tue, 19 May 2026 09:00:00 -0400 MDBH O.59331052 http://www.streetinsider.com/Globe+Newswire/PatentVest+Launches+New+Case+Studies+Section+Featuring+Strategic+AI+IP+Engagement+with+Docana/26518364.html <p align="center">· New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP positioning.</p> <p align="center">· The launch introduces a new Case Studies section on the PatentVest website focused on real-world examples of strategic IP leadership and innovation management.</p> <p align="left">Dallas, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the launch of a new Case Studies section on its website, beginning with a featured engagement with Docana, an artificial intelligence company operating within http://www.streetinsider.com/Globe+Newswire/PatentVest+Launches+New+Case+Studies+Section+Featuring+Strategic+AI+IP+Engagement+with+Docana/26518364.html Tue, 19 May 2026 09:00:00 -0400 MDBH O.59331052 http://www.streetinsider.com/Globe+Newswire/PatentVest+Launches+New+Case+Studies+Section+Featuring+Strategic+AI+IP+Engagement+with+Docana/26518364.html <p align="center">· New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP positioning.</p> <p align="center">· The launch introduces a new Case Studies section on the PatentVest website focused on real-world examples of strategic IP leadership and innovation management.</p> <p align="left">Dallas, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the launch of a new Case Studies section on its website, beginning with a featured engagement with Docana, an artificial intelligence company operating within http://www.streetinsider.com/Globe+Newswire/PatentVest+Launches+New+Case+Studies+Section+Featuring+Strategic+AI+IP+Engagement+with+Docana/26518364.html Tue, 19 May 2026 09:00:00 -0400 MDBH O.59331052 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MDB+Capital+Holdings%2C+++++For%3A+Mar+31/26494873.html si-local-file:///var/storage/secattach/20260514/26494873.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MDB+Capital+Holdings%2C+++++For%3A+Mar+31/26494873.html Thu, 14 May 2026 16:09:00 -0400 MDBH O.59331052 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MDB+Capital+Holdings%2C+++++For%3A+Mar+31/26494873.html si-local-file:///var/storage/secattach/20260514/26494873.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MDB+Capital+Holdings%2C+++++For%3A+Mar+31/26494873.html Thu, 14 May 2026 16:09:00 -0400 MDBH O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDB+Capital+Holdings%2C+++++For%3A+Aug+14++Filed+by%3A+Torpey+Daniel+Thomas/26463035.html si-local-file:///var/storage/secattach/20260508/26463035.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDB+Capital+Holdings%2C+++++For%3A+Aug+14++Filed+by%3A+Torpey+Daniel+Thomas/26463035.html Fri, 08 May 2026 20:18:00 -0400 MDBH O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDB+Capital+Holdings%2C+++++For%3A+Aug+14++Filed+by%3A+Torpey+Daniel+Thomas/26463035.html si-local-file:///var/storage/secattach/20260508/26463035.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDB+Capital+Holdings%2C+++++For%3A+Aug+14++Filed+by%3A+Torpey+Daniel+Thomas/26463035.html Fri, 08 May 2026 20:18:00 -0400 MDBH O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDB+Capital+Holdings%2C+++++For%3A+Jun+17++Filed+by%3A+Torpey+Daniel+Thomas/26463034.html si-local-file:///var/storage/secattach/20260508/26463034.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDB+Capital+Holdings%2C+++++For%3A+Jun+17++Filed+by%3A+Torpey+Daniel+Thomas/26463034.html Fri, 08 May 2026 20:16:00 -0400 MDBH O.59331052 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDB+Capital+Holdings%2C+++++For%3A+Jun+17++Filed+by%3A+Torpey+Daniel+Thomas/26463034.html si-local-file:///var/storage/secattach/20260508/26463034.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDB+Capital+Holdings%2C+++++For%3A+Jun+17++Filed+by%3A+Torpey+Daniel+Thomas/26463034.html Fri, 08 May 2026 20:16:00 -0400 MDBH O.59331052 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++MDB+Capital+Holdings%2C+++++For%3A+Jun+17++Filed+by%3A+Torpey+Daniel+Thomas/26463033.html si-local-file:///var/storage/secattach/20260508/26463033.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++MDB+Capital+Holdings%2C+++++For%3A+Jun+17++Filed+by%3A+Torpey+Daniel+Thomas/26463033.html Fri, 08 May 2026 20:15:00 -0400 MDBH O.59331052 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++MDB+Capital+Holdings%2C+++++For%3A+Jun+17++Filed+by%3A+Torpey+Daniel+Thomas/26463033.html si-local-file:///var/storage/secattach/20260508/26463033.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++MDB+Capital+Holdings%2C+++++For%3A+Jun+17++Filed+by%3A+Torpey+Daniel+Thomas/26463033.html Fri, 08 May 2026 20:15:00 -0400 MDBH O.59331052 http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html <p align="center">· Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.</p> <p align="center">· PatentVest’s report reveals how intellectual property strategy, receptor-ratio engineering, and delivery platforms may determine the next leaders in obesity therapeutics.</p> <p>DALLAS, TX, May 08, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, <b>“The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market.”</b> This comprehensive study provides a strategic analysis of the rapidly http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html Fri, 08 May 2026 10:30:00 -0400 A.02973684 GPCR MDBH O.00285735 O.21830803 O.59331052 http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html <p align="center">· Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.</p> <p align="center">· PatentVest’s report reveals how intellectual property strategy, receptor-ratio engineering, and delivery platforms may determine the next leaders in obesity therapeutics.</p> <p>DALLAS, TX, May 08, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, <b>“The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market.”</b> This comprehensive study provides a strategic analysis of the rapidly http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html Fri, 08 May 2026 10:30:00 -0400 A.02973684 GPCR MDBH O.00285735 O.21830803 O.59331052 http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html <p align="center">· Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.</p> <p align="center">· PatentVest’s report reveals how intellectual property strategy, receptor-ratio engineering, and delivery platforms may determine the next leaders in obesity therapeutics.</p> <p>DALLAS, TX, May 08, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, <b>“The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market.”</b> This comprehensive study provides a strategic analysis of the rapidly http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html Fri, 08 May 2026 10:30:00 -0400 A.02973684 GPCR MDBH O.00285735 O.21830803 O.59331052 http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html <p align="center">· Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.</p> <p align="center">· PatentVest’s report reveals how intellectual property strategy, receptor-ratio engineering, and delivery platforms may determine the next leaders in obesity therapeutics.</p> <p>DALLAS, TX, May 08, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, <b>“The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market.”</b> This comprehensive study provides a strategic analysis of the rapidly http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html Fri, 08 May 2026 10:30:00 -0400 A.02973684 GPCR MDBH O.00285735 O.21830803 O.59331052 http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html <p align="center">· Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.</p> <p align="center">· PatentVest’s report reveals how intellectual property strategy, receptor-ratio engineering, and delivery platforms may determine the next leaders in obesity therapeutics.</p> <p>DALLAS, TX, May 08, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, <b>“The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market.”</b> This comprehensive study provides a strategic analysis of the rapidly http://www.streetinsider.com/Press+Releases/New+PatentVest+Pulse+Report+Maps+the+Triple-Agonist+Race+and+the+Emerging+Patent+Battle+Shaping+the+Post-GLP-1+Obesity+Market/26459120.html Fri, 08 May 2026 10:30:00 -0400 A.02973684 GPCR MDBH O.00285735 O.21830803 O.59331052